Teachers Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Teachers Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.93M	Buy	147,394 +118,270	+406%	+$2.06M	﹤0.01%	1736
2018 Q4	$384K	Buy	29,124 +3,740	+15%	+$74.7K	﹤0.01%	2617
2018 Q3	$933K	Buy	25,384 +77	+0.3%	+$2.47K	﹤0.01%	2347
2018 Q2	$886K	Buy	25,307 +6,583	+35%	+$252K	﹤0.01%	2393
2018 Q1	$871K	Buy	18,724 +116	+0.6%	+$4.25K	﹤0.01%	2279
2017 Q4	$698K	Buy	18,608 +3,459	+23%	+$151K	﹤0.01%	2410
2017 Q3	$807K	Buy	15,149 +655	+5%	+$38.9K	﹤0.01%	2356
2017 Q2	$826K	Buy	14,494 +2,431	+20%	+$122K	﹤0.01%	2337
2017 Q1	$648K	Hold	12,063	–	–	﹤0.01%	2404
2016 Q4	$688K	Buy	12,063 +925	+8%	+$56K	﹤0.01%	2371
2016 Q3	$692K	Sell	11,138 -268	-2%	-$18.9K	﹤0.01%	2288
2016 Q2	$645K	Buy	11,406 +8,985	+371%	+$546K	﹤0.01%	2280
2016 Q1	$155K	Hold	2,421	–	–	﹤0.01%	2860
2015 Q4	$341K	Hold	2,421	–	–	﹤0.01%	2627
2015 Q3	$234K	Hold	2,421	–	–	﹤0.01%	2827
2015 Q2	$367K	Buy	+2,421	New	+$400K	﹤0.01%	2711

Other funds holding KDNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teachers Advisors's KDNY Position: Q1 2019 in Review

Teachers Advisors increased its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 406% in Q1 2019, buying an estimated $2.06M and bringing the position to 147,394 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Teachers Advisors first reported a position in KDNY in Q2 2015 and has held it in 16 quarters since. 102 funds tracked by Wall St. Rank hold KDNY as of Q1 2019.

Teachers Advisors held 147,394 shares of Chinook Therapeutics, Inc. Common Stock worth $2.93M as of Q1 2019.
Teachers Advisors bought 118,270 Chinook Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $2.06M.
Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1736 holding.
Teachers Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 16 quarters since.
102 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.